Novo Nordisk A/S - Depositary Receipt (Common Stock)
GB ˙ LSE ˙ US6701002056
44,24 US$ ↓ −1,31 (−2,88%)
2026-06-01
DELAT PRIS
SecurityGB:0TDD / Novo Nordisk A/S - Depositary Receipt (Common Stock)
InstitutionEquitable Trust Co
Latest Disclosed Ownership13,132 shares
Latest Disclosed Value $ 482,601
Equitable Trust Co reports 72.24% decrease in ownership of 0TDD / Novo Nordisk A/S - Depositary Receipt (Common Stock)

On April 30, 2026 - Equitable Trust Co filed a 13F-HR form disclosing ownership of 13,132 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock) (GB:0TDD) valued at $476,560 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 47,310 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock). This represents a change in shares of -72.24% during the quarter. The current value of the position is $568,090 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-30 2026-03-31 13F Novo Nordisk AS ADR Com 670100205 13,132 -34,178 -72.24 483 -79.98 0.0131
2026-02-02 2025-12-31 13F Novo Nordisk A Com 670100205 47,310 -793 -1.65 2,407 -9.82 0.1075
2025-11-10 2025-09-30 13F Novo Nordisk A Com 670100205 48,103 -982 -2.00 2,669 -21.20 0.1227
2025-07-23 2025-06-30 13F Novo Nordisk A Com 670100205 49,085 -18,042 -26.88 3,388 -27.33 0.1688
2025-04-25 2025-03-31 13F Novo Nordisk A Com 670100205 67,127 -15,504 -18.76 4,661 -34.42 0.2582
2025-01-28 2024-12-31 13F Novo Nordisk A Com 670100205 82,631 -2,339 -2.75 7,108 -29.75 0.3967
2024-10-29 2024-09-30 13F Novo Nordisk A Com 670100205 84,970 -1,108 -1.29 10,117 -17.65 0.6492
2024-07-31 2024-06-30 13F Novo-Nordisk ADR Com 670100205 86,078 2,588 3.10 12,287 14.61 0.8451
2024-04-24 2024-03-31 13F Novo-Nordisk ADR Com 670100205 83,490 -1,244 -1.47 10,720 22.30 0.7435
2024-01-25 2023-12-31 13F Novo-Nordisk ADR Com 670100205 84,734 -2,933 -3.35 8,766 9.95 0.6590
2023-11-06 2023-09-30 13F Novo-Nordisk ADR Com 670100205 87,667 48,847 125.83 7,972 26.90 0.6591
2023-08-08 2023-06-30 13F Novo-Nordisk ADR Com 670100205 38,820 -334 -0.85 6,282 0.83 0.4805
2023-05-02 2023-03-31 13F Novo-Nordisk ADR Com 670100205 39,154 -3,940 -9.14 6,231 6.82 0.4907
2023-02-17 2022-12-31 13F Novo-Nordisk ADR Com 670100205 43,094 -4,606 -9.66 5,832 22.73 0.4596
2022-10-31 2022-09-30 13F Novo-Nordisk ADR Com 670100205 47,700 -5,622 -10.54 4,752 -20.01 0.3961
2022-07-15 2022-06-30 13F Novo-Nordisk ADR Com 670100205 53,322 13,118 32.63 5,941 33.06 0.4426
2022-05-06 2022-03-31 13F Novo-Nordisk ADR Com 670100205 40,204 34,678 627.54 4,465 621.32 0.2869
2022-01-31 2021-12-31 13F Novo-Nordisk ADR Com 670100205 5,526 0 0.00 619 16.79 0.0382
2021-10-26 2021-09-30 13F Novo-Nordisk ADR Com 670100205 5,526 -8 -0.14 530 14.22 0.0338
2021-08-03 2021-06-30 13F Novo-Nordisk ADR Com 670100205 5,534 84 1.54 464 26.43 0.0298
2021-05-14 2021-03-31 13F Novo-Nordisk ADR Com 670100205 5,450 0 0.00 367 -3.67 0.0273
2021-02-12 2020-12-31 13F Novo-Nordisk ADR Com 670100205 5,450 0 0.00 381 0.79 0.0283
2020-11-13 2020-09-30 13F Novo-Nordisk ADR Com 670100205 5,450 0 0.00 378 5.88 0.0322
2020-08-18 2020-06-30 13F Novo-Nordisk ADR Com 670100205 5,450 0 0.00 357 8.84 0.0328
2020-05-21 2020-03-31 13F Novo-Nordisk ADR Com 670100205 5,450 -1,099 -16.78 328 -13.46 0.0360
2020-02-18 2019-12-31 13F Novo-Nordisk ADR Com 670100205 6,549 29 0.44 379 12.46 0.0370
2019-11-19 2019-09-30 13F Novo-Nordisk ADR Com 670100205 6,520 0 0.00 337 1.20 0.0355
2019-08-16 2019-06-30 13F Novo-Nordisk ADR Com 670100205 6,520 15 0.23 333 -2.06 0.0353
2019-05-15 2019-03-31 13F Novo-Nordisk ADR Com 670100205 6,505 146 2.30 340 16.04 0.0393
2019-02-22 2018-12-31 13F Novo-Nordisk ADR Com 670100205 6,359 663 11.64 293 8.92 0.0388
2018-11-15 2018-09-30 13F Novo-Nordisk ADR Com 670100205 5,696 -51 -0.89 269 1.51 0.0313
2018-08-14 2018-06-30 13F Novo-Nordisk ADR Com 670100205 5,747 5,747 265 0.0336
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.